* 0419114
* SBIR Phase I: Sublancin 168 for Bacillus Spores Detection, Inactivation and Decontamination
* TIP,TI
* 07/01/2004,12/31/2004
* Guck Ooi, Sun BioMedical Technologies, Inc
* Standard Grant
* Om P. Sahai
* 12/31/2004
* USD 97,928.00

This Small Business Innovation Research (SBIR) Phase I project proposes to
develop methods to use Sublancin 168 for detection, inactivation and
decontamination of Bacillus spores.

The commercial application of this project will be in the area of detection and
control of Bacillus anthracis, the causative agent of anthrax.